The North America novel food ingredients market was valued at USD 16.5 billion in 2025. This market is expected to reach USD 52.0 billion by 2036, growing from USD 18.3 billion in 2026, at a CAGR of 11.0% from 2026 to 2036.

The market covers new and innovative food ingredients, including alternative proteins, novel and next-generation sweeteners, functional and bioactive ingredients such as probiotics, postbiotics, and novel fibers, algae and microalgae ingredients, and emerging ingredients such as cultivated and precision-fermentation products. These ingredients are defined by their newness and by their reliance on the FDA Generally Recognized as Safe framework and other regulatory pathways. Demand is driven by health and functional-nutrition trends, by sugar and salt reduction, by the growth of alternative proteins, and by sustainability and clean-label preferences. The United States accounts for the large majority of regional demand, and North America is a leading regional market, holding about 40% of global alternative-protein-ingredient demand.

Key Highlights – North America Novel Food Ingredients Market

• The North America novel food ingredients market is expected to reach USD 52.0 billion by 2036, at a CAGR of 11.0% from 2026 to 2036, driven by health, functional nutrition, sugar reduction, and alternative proteins.
• North America leads alternative proteins. North America held about 40.4% of the global alternative-protein-ingredients market in 2025, which was estimated at about USD 25.92 billion, and plant-based protein accounted for about 66.1% of that market.
• Novel sweeteners are scaling for sugar reduction. Demand for allulose and rare-sugar sweeteners surged as companies such as Tate & Lyle, Ingredion, and Cargill expanded clean-label sugar-reduction solutions, and the FDA excludes allulose from Added Sugars on labels.
• Functional ingredients are growing. Probiotics, postbiotics, human milk oligosaccharides, and novel fibers are expanding, and in 2024 Kerry Group secured FDA GRAS affirmation for postbiotic ingredients.
• Regulation is being reformed in 2026. In August 2026, the FDA published a proposed rule that would require companies to notify the agency when they market a substance based on a GRAS conclusion, changing the pathway for novel ingredients.
• Cultivated and fermentation ingredients advanced. Multiple cultivated-meat and precision-fermentation companies gained FDA clearance, and in August 2026 ADM invested about USD 55.5 million to convert an Iowa facility into a precision fermentation operation.
• Key companies include Archer-Daniels-Midland Company, Cargill, Incorporated, International Flavors & Fragrances Inc., dsm-firmenich AG, and Ingredion Incorporated.

Report Overview

The North America novel food ingredients market covers new and innovative food ingredients across several categories: alternative proteins from plants, fermentation, cultivation, and insects; novel and next-generation sweeteners such as allulose, rare sugars, and sweet proteins; functional and bioactive ingredients such as probiotics, postbiotics, human milk oligosaccharides, novel fibers, and phytochemicals; algae and microalgae ingredients; and emerging ingredients from cultivated and precision-fermentation technologies. These ingredients are defined by their newness and by their reliance on the FDA Generally Recognized as Safe framework and other regulatory pathways, which distinguishes them from established commodity ingredients. Demand is concentrated in the United States and is shaped by health and functional-nutrition trends, sugar and salt reduction, alternative-protein growth, and clean-label and sustainability preferences. This report examines the size, drivers, segmentation, countries, pricing, competition, recent developments, and outlook of the market, and provides recommendations for participants. Sizing is built bottom-up from ingredient demand across food, beverage, and supplement applications.

Key Market Dynamics

Market Drivers

The main drivers of the North America novel food ingredients market are health and functional-nutrition trends, sugar and salt reduction, and the growth of alternative proteins. Health and functional nutrition are strong drivers, as consumers seek ingredients with recognisable benefits such as gut health, and probiotics, postbiotics, human milk oligosaccharides, and novel fibers are expanding, with Kerry Group securing FDA GRAS affirmation for postbiotics in 2024. Sugar reduction is a major driver, as novel sweeteners such as allulose and rare sugars enable clean-label sugar reduction across beverages, bakery, and dairy, and companies including Tate & Lyle, Ingredion, and Cargill have expanded these solutions. Alternative-protein growth drives demand for plant, fermentation, and cultivated proteins, with the global alternative-protein-ingredients market at about USD 25.92 billion in 2025 and North America holding about 40.4%. These factors, health and functional nutrition, sugar reduction, and alternative proteins, are the main drivers, supported by clean-label and sustainability preferences.

Key Opportunities

The market offers opportunities in novel sweeteners for sugar reduction, in functional and bioactive ingredients, and in fermentation-derived and alternative proteins. Novel sweeteners are a large opportunity, because sugar reduction is a priority across food and beverage and allulose, rare sugars, and sweet proteins provide clean-label options, supported by favourable labeling such as the exclusion of allulose from Added Sugars. Functional and bioactive ingredients, including probiotics, postbiotics, human milk oligosaccharides, and novel fibers, are a growing opportunity as functional foods, supplements, and infant nutrition expand. Fermentation-derived and alternative proteins are an opportunity as precision fermentation and plant proteins scale, illustrated by ADM's investment in precision fermentation and by expanding commercial production from Perfect Day and others. These areas, novel sweeteners, functional and bioactive ingredients, and fermentation and alternative proteins, are the main opportunities, alongside algae ingredients and emerging cultivated products.

Market Trends

Current trends include regulatory reform, the scaling of alternative and fermentation proteins, sugar-reduction innovation, and investment and consolidation. Regulatory reform is a defining trend, with the FDA proposing in August 2026 to require notification for GRAS conclusions and steadily issuing GRAS clearances, including for microbial ingredients, sweeteners, and human milk oligosaccharides. Alternative and fermentation proteins are scaling, with cultivated-meat and precision-fermentation companies gaining FDA clearance and expanding production. Sugar-reduction innovation continues, with allulose, rare sugars, and fiber-based solutions growing. Investment and consolidation are active, with ADM, Cargill, and IFF investing in fermentation and specialty ingredients and raising R&D. These trends indicate a dynamic market advancing across novel categories under evolving regulation.

Report Summary

Segmental Analysis

Market by Ingredient Type

By ingredient type, the market comprises alternative proteins, novel sweeteners, functional and bioactive ingredients, algae and microalgae, and others. Alternative proteins hold the largest share, at about 40% of the market in 2026, with the remaining share divided across novel sweeteners, functional and bioactive ingredients, algae, and others. Alternative proteins, spanning plant proteins, which account for about two-thirds of the alternative-protein-ingredients market, and fermentation, cultivated, and insect proteins, are the largest category, driven by demand for sustainable and plant-based nutrition. Novel sweeteners, including allulose, rare sugars, and sweet proteins, are a growing category driven by sugar reduction. Functional and bioactive ingredients, including probiotics, postbiotics, human milk oligosaccharides, and novel fibers, serve functional and gut-health products. Algae and microalgae ingredients provide protein, omega-3, and color, and other emerging ingredients, including novel botanicals, complete the category.

Market by Source

By source, the market comprises plant-based, microbial and fermentation, algae, and cell-cultured and other sources. Plant-based ingredients hold the largest share, at about 55% of the market in 2026, with the remaining share divided across microbial and fermentation, algae, and cell-cultured and other sources. Plant-based ingredients, including plant proteins, fibers, and botanical extracts, are the largest source because of the scale of plant-based protein and clean-label demand. Microbial and fermentation ingredients, including fermentation-derived proteins, sweeteners, and functional ingredients, are a fast-growing source as precision fermentation scales. Algae and microalgae provide protein and specialty ingredients. Cell-cultured and other sources, including cultivated products, are emerging. The dominance of plant-based ingredients reflects the scale of alternative proteins and clean-label preferences.

Market by Application

By application, the market comprises food and beverages, dietary supplements and nutraceuticals, infant nutrition, sports nutrition, and other uses. Food and beverages hold the largest share, at about 60% of the market in 2026, with the remaining share divided across supplements, infant nutrition, sports nutrition, and other uses. Food and beverage demand, using alternative proteins, novel sweeteners, and functional ingredients across meat alternatives, beverages, bakery, dairy, and confectionery, is the core of the market. Dietary supplements and nutraceuticals use probiotics, postbiotics, and bioactives. Infant nutrition uses human milk oligosaccharides and specialty ingredients. Sports nutrition uses proteins and functional ingredients. Other uses complete the segment. The concentration in food and beverages reflects the scale and diversity of that application.

Geographic Analysis

United States Novel Food Ingredients Market

The United States is by far the largest market in the region, accounting for the large majority of demand and hosting most of the leading ingredient companies and innovators. The scale reflects a large and innovative food and beverage industry, strong functional-nutrition and sugar-reduction demand, and the concentration of alternative-protein, fermentation, and novel-ingredient companies, and the U.S. alternative-protein-ingredients market alone was about USD 7.70 billion in 2024. The FDA GRAS framework governs novel ingredients, and the proposed 2026 rule requiring notification for GRAS conclusions will shape the pathway. Supply is led by Archer-Daniels-Midland Company, Cargill, Incorporated, International Flavors & Fragrances Inc., dsm-firmenich AG, Ingredion Incorporated, Tate & Lyle PLC, and Kerry Group, alongside innovators in fermentation and cultivated products. The United States sets the pace for demand, innovation, and regulation across the region.

Canada Novel Food Ingredients Market

Canada is a significant secondary market with strong food-innovation, plant-protein, and clean-label sectors, supported by a large agricultural base and government interest in plant-based and sustainable foods. Demand is driven by alternative proteins, novel sweeteners, and functional ingredients, and by consumer preference for health and natural products. Supply is drawn from North American and international companies, and Canada has a notable plant-protein industry. Health Canada regulates novel foods through its own framework. The country's agricultural base and innovation programs support growth.

Pricing Analysis

Pricing in novel food ingredients varies widely by category, reflecting the stage of technology, scale, and regulatory status. Established plant proteins and some novel sweeteners are priced competitively at scale, while newer ingredients such as precision-fermentation proteins, cultivated products, human milk oligosaccharides, and sweet proteins carry higher prices tied to their production cost and early scale. The value of health and functional benefits, clean-label positioning, and sugar reduction supports pricing for many novel ingredients even where they cost more than the ingredients they replace.

Several factors set price. Technology and scale are central, with early-stage fermentation and cultivated ingredients priced above mature plant and commodity ingredients, and prices falling as production scales. Regulatory status and the cost of GRAS and other clearances affect price, since novel ingredients face 12 to 18 month notification timelines and development costs that add to the cost base. Functional and health value increasingly justify price, as ingredients delivering gut-health, sugar-reduction, or nutritional benefits carry worth for brands. Feedstock and input cost affect production. Application and volume matter, with high-volume food and beverage uses supporting competitive pricing and specialty and infant-nutrition ingredients higher margins. The trajectory of pricing depends on scaling newer ingredients toward cost parity and on the evolving regulatory framework.

Competitive Landscape

The competitive field combines large ingredient companies with innovators in novel categories. Among the majors, Archer-Daniels-Midland Company and Cargill, Incorporated produce a broad range of novel and specialty ingredients and are investing in fermentation and alternative proteins, with ADM investing in precision fermentation and Cargill maintaining a large fermentation network; International Flavors & Fragrances Inc., dsm-firmenich AG, and Kerry Group plc supply functional, bioactive, and specialty ingredients; and Ingredion Incorporated, Tate & Lyle PLC, and Roquette Freres are leaders in plant proteins, novel sweeteners, and fibers. Corbion N.V., Givaudan SA, and Novonesis contribute fermentation-derived and specialty ingredients.

Among innovators, Perfect Day, Inc. and other precision-fermentation companies produce animal-free proteins, cultivated-meat companies advance toward commercialisation, and specialists develop novel sweeteners, algae ingredients, and functional bioactives. Competition turns on innovation and technology, regulatory clearance, product performance and functional benefit, and the ability to scale novel ingredients to cost-competitive volumes. Regulatory reform, investment, and the scaling of fermentation and alternative proteins are shaping the field, and companies that combine innovation, regulatory capability, and scale, whether large ingredient companies or specialists partnering with them, are best positioned.

Key Players

The active companies in the market as of September 2026 include:

• Archer-Daniels-Midland Company
• Cargill, Incorporated
• International Flavors & Fragrances Inc.
• dsm-firmenich AG
• Ingredion Incorporated
• Tate & Lyle PLC
• Kerry Group plc
• Corbion N.V.
• Givaudan SA
• Novonesis (Novozymes A/S)
• Roquette Freres
• Perfect Day, Inc.

Voice of Customer

Product development lead, food and beverage company (United States): "Novel ingredients let us hit health and sugar-reduction goals and offer plant-based and functional products, from allulose in beverages to postbiotics in supplements. The considerations are regulatory clearance, cost against conventional ingredients, and whether the ingredient performs, and we work with suppliers who can prove GRAS status and deliver at our volumes."

Regulatory affairs manager, ingredient company (United States): "The GRAS framework is how novel ingredients reach the U.S. market, and the proposed rule requiring notification will change how we plan launches. Timelines and evidence are the constraint, so we build the safety case early. The direction of regulation is toward more transparency, which we plan around."

Innovation director, supplement brand (United States): "Functional ingredients like probiotics, postbiotics, and novel fibers are where demand is growing, and consumers understand gut health. We prioritise ingredients with a credible benefit, a clean label, and regulatory clearance, and we watch the fermentation and cultivated space for the next generation of ingredients."

Analyst Perspective

North American novel food ingredients is a dynamic, fast-growing market spanning several innovative categories united by their newness and their reliance on the GRAS pathway. Alternative proteins are the largest category, with North America holding about 40% of global demand and plant proteins about two-thirds of that, and novel sweeteners, functional and bioactive ingredients, and emerging fermentation and cultivated products add fast-growing segments. Health and functional nutrition, sugar reduction, and sustainability are durable drivers, and the region leads on innovation and hosts most of the leading companies.

The defining considerations are regulation and scale. The GRAS framework governs how novel ingredients reach the market, with notification timelines of 12 to 18 months, and the FDA proposal in August 2026 to require notification for GRAS conclusions marks a shift toward greater transparency that will shape launches. Newer ingredients such as precision-fermentation proteins, cultivated products, and sweet proteins remain more expensive than the ingredients they replace and depend on scaling toward cost parity, so the pace of commercialisation matters as much as the science. Alternative proteins have also seen demand normalise after a period of hype, so the market should be assessed category by category rather than as a single trend. Companies that combine innovation, regulatory capability, and the scale to reach cost-competitive volumes are best positioned, and large ingredient companies partnering with or acquiring innovators are well placed across the novel categories.

Key Strategic Developments

• August 2026: The FDA published a proposed rule on substances Generally Recognized as Safe that would require companies to notify the agency when they market a substance based on a GRAS conclusion, a significant change to the pathway through which novel food ingredients reach the U.S. market.
• First quarter of 2026: The FDA issued "no questions" GRAS letters for a range of novel ingredients, including microbial substances, sugar-substitute ingredients, and human milk oligosaccharides, reflecting steady clearance of novel food ingredients.
• August 2026: Archer-Daniels-Midland Company invested about USD 55.5 million to convert an underutilised fermentation facility in Clinton, Iowa, into a precision fermentation operation to produce high-value proteins and enzymes, expanding capacity in fermentation-derived ingredients.
• February-March 2026: Precision-fermentation companies expanded commercial production, with Perfect Day, Inc. scaling animal-free dairy proteins and The EVERY Company accelerating animal-free egg proteins, advancing fermentation-derived novel ingredients.
• 2026: Cultivated-meat and cultivated-fat companies continued to gain FDA clearance and advance toward commercialisation, extending the range of novel food ingredients reaching the market.

Strategic Recommendations

For companies, the priority is to combine innovation with regulatory capability and a credible path to scale, because novel ingredients reach the market through the GRAS pathway and their success depends on clearance, functional benefit, and cost-competitive volumes. Companies should build safety and GRAS cases early and plan for the proposed notification requirement, invest in scaling newer ingredients such as fermentation-derived proteins and novel sweeteners toward cost parity, and focus on categories with durable demand such as sugar reduction and functional nutrition. Large ingredient companies should continue to partner with or acquire innovators to access novel categories, and innovators should partner for scale and distribution.

For food, beverage, and supplement companies, the recommendation is to adopt novel ingredients to meet health, sugar-reduction, and sustainability goals, evaluating them on regulatory clearance, functional benefit, and cost, and to plan for evolving GRAS requirements. For regulators, clear and transparent GRAS processes support both safety and innovation, and the proposed notification rule moves in that direction. For investors, this is a market to evaluate category by category on innovation, regulatory clearance, functional benefit, and the path to cost-competitive scale rather than as a single trend, recognising that durable health and sustainability drivers support growth while regulation and scale determine which ingredients and companies succeed.